A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations
- PMID: 38136976
- PMCID: PMC10743207
- DOI: 10.3390/genes14122154
A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations
Abstract
Mitochondrial disorders are characterized by a huge clinical, biochemical, and genetic heterogeneity, which poses significant diagnostic challenges. Several studies report that more than 50% of patients with suspected mitochondrial disease could have a non-mitochondrial disorder. Thus, only the identification of the causative pathogenic variant can confirm the diagnosis. Herein, we describe the diagnostic journey of a family suspected of having a mitochondrial disorder who were referred to our Genetics Department. The proband presented with the association of cerebellar ataxia, COX-negative fibers on muscle histology, and mtDNA deletions. Whole exome sequencing (WES), supplemented by a high-resolution array, comparative genomic hybridization (array-CGH), allowed us to identify two pathogenic variants in the non-mitochondrial SYNE1 gene. The proband and her affected sister were found to be compound heterozygous for a known nonsense variant (c.13258C>T, p.(Arg4420Ter)), and a large intragenic deletion that was predicted to result in a loss of function. To our knowledge, this is the first report of a large intragenic deletion of SYNE1 in patients with cerebellar ataxia (ARCA1). This report highlights the interest in a pangenomic approach to identify the genetic basis in heterogeneous neuromuscular patients with the possible cause of mitochondrial disease. Moreover, even rare copy number variations should be considered in patients with a phenotype suggestive of SYNE1 deficiency.
Keywords: SYNE1; WES; array-CGH; mitochondrial disorder.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Theunissen T.E.J., Nguyen M., Kamps R., Hendrickx A.T., Sallevelt S.C.E.H., Gottschalk R.W.H., Calis C.M., Stassen A.P.M., de Koning B., Mulder-Den Hartog E.N.M., et al. Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause. Front. Genet. 2018;9:400. doi: 10.3389/fgene.2018.00400. - DOI - PMC - PubMed
-
- Schon K.R., Horvath R., Wei W., Calabrese C., Tucci A., Ibañez K., Ratnaike T., Pitceathly R.D.S., Bugiardini E., Quinlivan R., et al. Use of Whole Genome Sequencing to Determine Genetic Basis of Suspected Mitochondrial Disorders: Cohort Study. BMJ. 2021;375:e066288. doi: 10.1136/bmj-2021-066288. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
